Penmenvy
Payments companies reported to CMS as associated with Penmenvy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Penmenvy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Penmenvy
These are the largest totals companies reported as associated with Penmenvy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Corey Hebert | Gretna, LA | Pediatrics | $68,447.67 |
| Andrew Arthur | Tucson, AZ | Pediatrics | $29,272.97 |
| Jennifer Coren | Hatboro, PA | Pediatrics | $20,890.30 |
| Anita Chandra Puri | Chicago, IL | Pediatrics | $17,376.27 |
| Jon Dvorak | Perrysburg, OH | Pediatrics | $15,340.45 |
| Kenneth Saul | Thousand Oaks, CA | Pediatrics | $10,526.73 |
| Warren Seigel | Brooklyn, NY | Pediatrics | $9,181.23 |
| Eric Schnakenberg | Halfmoon, NY | Family Medicine | $8,445.67 |
| Shweta Chawla | Chicago Heights, IL | Pediatrics | $8,320.64 |
| Bernard Wosk | Escondido, CA | Pediatrics | $6,986.54 |
Prescribed Penmenvy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.